Prediction Case File
YouTubeEvaluation Complete

BROADCAST: http://t.me/planfomolive

2 extracted signals · 2 resolved · 0 still active

Planfomo profile imagePlanfomo15 May 2025, 09:33 UTC
Video preview for BROADCAST: http://t.me/planfomolive
Signals
2
Eligible signals in this source
Open
0
Still being tracked
Resolved
2
Evaluable outcomes
Successful
0
Canonical correct result
Failed
2
Canonical failed result
Resolved success
0%
Open and excluded signals omitted
Source overview

AI-generated source summary

The speaker provides a technical analysis of ETHUSDT and BTCUSDT using weekly charts, identifying resistance levels and expected retracement to support. ETHUSDT is facing a rejection and a massive area of resistance. A breakdown of an ascending support is expected, retesting the ascending resistance level with the price then potentially reaching a target price of $1,679.00. BTCUSDT is facing strong resistance which may trigger a return to $80,000. Chainlink is showing a similar market structure of altcoins to Ethereum and Bitcoin.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    2 eligible signals linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Planfomo

Tracked signals
74
Historical success
33.8%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.